InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-17.9%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by HOLLER FRANK A, Director. Officer active across 2 companies, notably Xenon Pharmaceuticals Inc.. Cumulatively, 2 filings have been published. History available since 27 May 2021. The latest transaction was filed on 27 May 2021 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Declarations2 total
3,086 shares@ US$3.760.0002% mcap50.0% of flowCommon SharesSEC:0001209191-21-036798:0
3,086 shares@ US$3.7650.0% of flowCommon SharesSEC:0001209191-21-036798
2 of 2 declarations
About HOLLER FRANK A
Frank A. Holler is a Board Member at Xenon Pharmaceuticals Inc. He plays a crucial role in the governance of the company, providing strategic advice and oversight of operations. His experience in the pharmaceutical sector allows him to contribute to the innovation and growth of Xenon Pharmaceuticals. As a board member, he participates in critical decision-making for the company's future.
